4.1 Review

H5N1 influenza virulence, pathogenicity and transmissibility: what do we know?

Journal

FUTURE VIROLOGY
Volume 10, Issue 8, Pages 971-980

Publisher

FUTURE MEDICINE LTD
DOI: 10.2217/FVL.15.62

Keywords

H5N1; HA; influenza; NS1; pathogenicity; PB1-F2; PB2; virulence

Categories

Funding

  1. Center for Research on Influenza Pathogenesis (CRIP)
  2. NIAID [HHSN272201400008C]
  3. [R01 AI069274]
  4. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069274] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Highly pathogenic influenza viruses of the H5N1 subtype have infected more than 600 people since 1997, resulting in the deaths of approximately 60% of those infected. Multiple studies have established the viral hemagglutinin (HA) surface glycoprotein as the major determinant of H5N1 virulence. HA mediates host-specific virus binding to cells, and mutations that allow efficient binding to viral receptors on mammalian cells are critical (although not sufficient) for H5N1 transmissibility among mammals. The viral polymerase PB2 protein is also a critical virulence determinant, and adaptive mutations in this protein are crucial for efficient H5N1 virus replication in mammals. Additionally, viral proteins (such as NS1 and PB1-F2) with roles in innate immune responses also affect the virulence of highly pathogenic H5N1 viruses.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available